Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Knowing when to rebalance your investment portfolio is crucial for success. Learn key timing insights to optimize your financial strategy.
20,317 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
A Bank of America note urged clients to lock in gains as the market shifted from growth to defensives. The Nasdaq fel...
Retirement savings isn t about a single age. It s about momentum, smart accounts, and consistent habits. This guide e...
A late-night joke becomes a financial brain-teaser: how the trillionaire milestone reframes wealth and what it means ...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...
Alphabet raising $84.75 billion marks a bold turn in how tech giants fund AI bets. This article breaks down what it c...
Xenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
Karman Space & Defense reported a solid quarter, but its stock slipped. This article breaks down the factors behind t...
A surprising moment from popular culture becomes a blueprint for smarter money choices. This guide translates that le...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...